Skip to main content
Caplight Logo









Beijing GenomePrecision Technology Co., Ltd.

Beijing GenomePrecision Technology Co., Ltd.

Private
BeijingHealthcare & Life Scienceshttps://www.genomeprecision.com/

Last Round

Series C

Apr 19, 2021

Total Funding Raised

$20.17M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Beijing GenomePrecision Technology Co., Ltd. is a biotechnology company that develops and manufactures molecular diagnostic products for precision medicine, focusing on hematologic oncology, transplantation, and infectious diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Healthcare Analytics

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

genomic testingmolecular diagnosticsprecision medicineoncology testingbioinformaticsgenetic screeninghigh-throughput sequencingclinical diagnosticsreproductive health screeninghereditary disease testingnext-generation sequencingNGSbiotechdiagnostic kitsgenomic data analysis

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Beijing GenomePrecision Technology Co., Ltd. Comparables

Compare Beijing GenomePrecision Technology Co., Ltd. with similar companies based on industry and business-model similarity.

Beijing GenomePrecision Technology Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Annoroad Gene Technology
88%
Beijing Geneplus Technology
86%
Berry Genomics Co., Ltd.
83%

Beijing GenomePrecision Technology Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CApr 19, 2021
Series BFeb 18, 2019
Series AJun 6, 2017

Beijing GenomePrecision Technology Co., Ltd. Investors

Notable investors and investment history

Beijing GenomePrecision Technology Co., Ltd. investors
InvestorRounds
Oriental Fortune CapitalSeries C
YuanBio Venture CapitalSeries A
Zhejiang Jiuren Capital Management Co., Ltd.Series B
华创资本Series B
Guiyang City Venture Capital Co., Ltd.Series C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors grew 4076% MoM, from 29 to 1.2K.

  • Apr 19, 2021

    $5.37M round with Oriental Fortune Capital and Guiyang City Venture Capital.

Beijing GenomePrecision Technology Co., Ltd. Filings

Explore SEC and related filing metadata, where available.

Beijing GenomePrecision Technology Co., Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Beijing GenomePrecision Technology Co., Ltd.'s valuation, stock price, and market status.

Is Beijing GenomePrecision Technology Co., Ltd. a public or private company?

Beijing GenomePrecision Technology Co., Ltd. is a private company.

What is the current stock price of Beijing GenomePrecision Technology Co., Ltd.?

Beijing GenomePrecision Technology Co., Ltd. is a private company with no public stock price. Caplight tracks Beijing GenomePrecision Technology Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Beijing GenomePrecision Technology Co., Ltd. worth (valuation)?

Valuation information for Beijing GenomePrecision Technology Co., Ltd. is not publicly available.

Can I buy Beijing GenomePrecision Technology Co., Ltd. stock?

Beijing GenomePrecision Technology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Beijing GenomePrecision Technology Co., Ltd.'s last funding round?

Beijing GenomePrecision Technology Co., Ltd.'s most recent funding round was Series C on April 19, 2021.

Who are the main investors in Beijing GenomePrecision Technology Co., Ltd.?

Key investors in Beijing GenomePrecision Technology Co., Ltd. include Oriental Fortune Capital, YuanBio Venture Capital, Zhejiang Jiuren Capital Management Co., Ltd., 华创资本, Guiyang City Venture Capital Co., Ltd..

Will Beijing GenomePrecision Technology Co., Ltd. IPO soon?

No public IPO plans have been announced for Beijing GenomePrecision Technology Co., Ltd..

How can I track Beijing GenomePrecision Technology Co., Ltd. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Beijing GenomePrecision Technology Co., Ltd.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBeijing
Employee Range3
Year Founded2015
Last FundingApr 19, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?